Decheng Capital Management Iii (Cayman), LLC Equillium, Inc. Call Options Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EQ
# of Institutions
30Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital LLC Menlo Park, CA4.45MShares$2.53 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$479,9100.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$320,498100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$153,6150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$111,7710.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $19.6M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...